PNPLA3 148M functions to sequester ABHD5 and prevent coactivation of PNPLA2, which has implications for initiating MASLD; however, the exact mechanisms involved are not understood. The gene discussed is ABHD5; the disease is metabolic dysfunction-associated steatotic liver disease.